Terminal
Stocks
Spotlight
Research

Stocks
Industrials
NASDAQ
ULBI

Market Cap: $93.28M

UC

Ultralife Corporation

ULBI

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin23.86%

EBITDA Margin-0.33%

EBIT Margin-3.20%

Pre-tax Margin-5.15%

Net Profit Margin-3.50%

Earnings Yield-7.02%

Valuation Multiples

Price / Book0.70

Price / Sales0.50

Price / Earnings-13.99

PEG0.06

Forward PEG-0.61

EV / Sales0.72

EV / EBITDA-213.91

EV / Operating Cash Flow26.14

EV / Free Cash Flow66.04

Price / Free Cash Flow45.93

Price / Operating Cash Flow18.18

Cash Flow & Capital

Free Cash Flow / Share$0.12

Operating Cash Flow / Share$0.31

Free Cash Flow Yield2.18%

Capex / Revenue1.66%

Capex / Operating Cash Flow60.42%

Capex / Depreciation0.58

Stock Compensation / Revenue0.30%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.87

Quick Ratio1.30

Cash Ratio0.18

Debt / Assets0.22

Debt / Capital0.26

Debt / Equity0.36

Long-Term Debt / Capital0.24

Debt / Market Cap48.80%

Net Debt / EBITDA-65.15

Solvency Ratio-0.01

Financial Leverage1.63

Efficiency & Working Capital

Asset Turnover0.87

Fixed Asset Turnover4.74

Inventory Turnover2.43

Receivables Turnover5.39

Payables Turnover6.31

Days Sales Outstanding67.78

Days Inventory Outstanding150.41

Days Payables Outstanding57.87

Operating Cycle218.19

Cash Conversion Cycle160.32

Working Capital Turnover2.74

Returns & Quality

Return on Equity-4.95%

Return on Assets-3.03%

Return on Invested Capital1.92%

ROCE2.82%

Return on Tangible Assets-4.08%

Operating Return on Assets2.31%

Income Quality-0.77

Tax Burden0.68

Interest Burden1.61

Balance Sheet & Intrinsic Metrics

Enterprise Value$134.12M

Invested Capital$165.07M

Working Capital$69.8M

Tangible Asset Value$76.85M

Net Current Asset Value$23.6M

Graham Net-Net-$1.29

Book Value / Share$7.96

Tangible Book Value / Share$4.61

Cash / Share$0.4

Financial Health Scores

Piotroski Score5

Altman Z-Score1.59

Revenue$187.24M

EBIT$-6M

Market Cap$94.11M

Working Capital$69.8M

Retained Earnings$-38.25M

Total Assets$216.16M

Total Liabilities$83.56M